We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Hvivo Plc | LSE:HVO | London | Ordinary Share | GB00B9275X97 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.05 | 0.18% | 28.00 | 27.50 | 28.10 | 27.95 | 27.80 | 27.95 | 805,775 | 16:35:12 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 48.48M | -776k | -0.0011 | -252.73 | 187.67M |
Date | Subject | Author | Discuss |
---|---|---|---|
20/3/2024 14:55 | Bought back APH , results in 2 weeks, dividend likely reinstate | blackhorse23 | |
20/3/2024 12:10 | You're the bad omen here 666 ;))) | baldrick1 | |
20/3/2024 10:28 | quoted 29.35p at 10.27am to sell | 666james | |
20/3/2024 10:20 | What a nice empty thread now I’ve filtered all the people that keep responding to not a sikh and not tech. Its not banter guys its just tediously boring litter. | yump | |
20/3/2024 08:12 | Mo said in his last presentation that results would be early April | inaminute | |
20/3/2024 05:55 | With revenue coverage for the year basically done but moving into Canary Wharf in July, you can understand why the Octopus Fund Manager in the video I posted is confident that Mo Khan is still in underpromise overdeliver mode and that there may be further upward revisions to expectations for 2024. And don't forget the operational gearing that would come off the back of that. | dan_the_epic | |
20/3/2024 02:46 | oldvic Last year the results for year ending, 31/12/22 was released on the 25/04/23 so would expect result for year ending, 31/12/23 will be released sometime in April 2024. | curnic1 | |
20/3/2024 01:26 | Looking good.. And I think ConserV Bioscience-Imutex will pay off as well.They're now working with the Walter Reed Army institute of Research in the US for the mosquito candidate. They're getting lots of government funding on both side of the pond. | chica1 | |
20/3/2024 01:17 | When exactly are the results? | oldvic | |
19/3/2024 21:20 | Pierre, "Every quoted company has senior positions motivated by options" Can you name the companies where ONE director, the CEO, has so many options and those companies have performed well? I can give you an example of where the company's shares crashed. At rthm, it was a similar situation. The CEO, alone, was awarded 7m options. I warned of the red flags. The shares crashed shortly Despite those options awarded to ONE director, the CEO, I still sold a month later at around 590p(new money). Despite those options, the shares crashed from 590p(new money) to 100p, as I predicted, due to questionable business model. The were talked up. "The key point here is institutions are now taking notice and buying." You're changing the metric again. If it's a key point then a massive c40% of TLY are ALREADY held by institutions and they have been increasing. Yet there you deramping using different metrics!!! Isn't it a key point there as well. Make up your mind. Is it a key point when it suits you? | sikhthetech | |
19/3/2024 19:07 | LFDKMP "Trade 182 at 13.46 - 2.73 million. The big boys are arriving :-)" 2.73m is around 1/3 of the CEO's options, awarded a year ago and exercisable from a year With that 2.73m, it makes the CEO's > 7m options huge, doesn't it? How does it compare to the 25m the Chairman/Founder dumped recently? It's about 1/10th of the shares he dumped. | sikhthetech | |
19/3/2024 17:56 | Haha you've been saying the same since 22p "I take it you'll be buying at 22p, not selling a share, and holding" the answer was and always is, YES | discojames | |
19/3/2024 17:29 | Trade 182 at 13.46 - 2.73 million The big boys are arriving :-) ( sorry, almost forgot my political correctness. the big boys/ big girls and big gender non specifics) | lfdkmp | |
19/3/2024 14:32 | 1gw, It's good you're loading up at 30p and won't sell a single share. Unless you and your mates are pulling the wool over PIs eyes by manipulating the shares, as you usual do? Given you portray yourself as a well research poster, why do virtually all your and your mates shares crash?. Crucially, why do virtually all your stories turn out to be false, fantasies?. Byot down 95%, Trmr down 80%, blnx down 90%, rthm down 80%, Stu bust, Nano down 60% etc etc How many multiple ids do you have and why? | sikhthetech | |
19/3/2024 14:26 | 32p uncrossing trade at 2pm. | 1gw | |
19/3/2024 14:07 | Topped up as this fell after CFs sale. No way this was ever going to be below 28p when results come out. As I keep saying the buyers of CFs shares will have had a very deep briefing before they took those off him. | inaminute | |
19/3/2024 14:03 | Yep, this is almost definitely heading to 34p area.....the CF sale and JM purchase are both huge positives.....someon | hotteruk6 | |
19/3/2024 13:35 | Lauders, "Would be wonderful if a new contract was announced pre-results or on the day itself." Coming up to end of Q1 already, there's been no contracts added to this year's order book. | sikhthetech | |
19/3/2024 13:33 | Just trader talk and small trades to push the share price higher. Note Nexn(ex blnx/trmr) thread was busy yesterday whilst here was quiet. Lots of trades on nexn yesterday and hardly any today. Vice versa today. 1gw and his mates moving around from 1 share to another. lol | sikhthetech | |
19/3/2024 13:15 | Looks like we will be back through 30p just in time for results. Then the trend can continue if the good news also continues. Don't see why it should suddenly change. Would be wonderful if a new contract was announced pre-results or on the day itself. That would really help things shift gear! | lauders |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions